Home » Genzyme Sharpens Drug Sales View After Plant Woes
Genzyme Sharpens Drug Sales View After Plant Woes
Genzyme Corp sharpened its revenue forecast for two important medicines for treating rare diseases, as the company gains greater clarity on supply shortages stemming from problems at a key manufacturing plant.
Forbes
Forbes
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May